HAVN Life Sciences Inc. (HAVLF)
| Market Cap | 29.00 -99.9% |
| Revenue (ttm) | 440.11K +876.8% |
| Net Income | -11.78M |
| EPS | -1.65 |
| Shares Out | 28.65M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,430 |
| Open | 0.000001 |
| Previous Close | 0.000001 |
| Day's Range | 0.000001 - 0.000001 |
| 52-Week Range | n/a |
| Beta | 96.95 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About HAVN Life Sciences
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and... [Read more]
News
HAVN Life Announces a 30:1 Consolidation of its Common Shares
VANCOUVER, British Columbia, July 29, 2022 (GLOBE NEWSWIRE) -- HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company” or "HAVN Life") a biotechnology company pursuing standardiz...
HAVN Life To Be Featured On Viewpoint with Dennis Quaid
The Company's segment will be aired on public television networks across the U.S. starting in July, with interviews featuring CEO Tim Moore and the team leading HAVN Life's Research and Development VA...
HAVN Life to Present at Upcoming LD Micro Invitational XII
CEO, Tim Moore will share recent partnership and distribution news and a roadmap for the Company's plans for the next quarterVancouver, British Columbia--(Newsfile Corp. - June 6, 2022) - Havn Life Sc...
HAVN Life Sciences Inc. to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022
VANCOUVER, BC / ACCESSWIRE / April 30, 2022 / HAVN Life Sciences Inc. (CSE:HAVN) (OTC:HAVLF) (FSE:5NP) , a biotechnology company pursuing standardized extraction of psychedelic compounds for investiga...
HAVN Life Session at Psychedelic Capital: Jan 2022 by Microdose
Tim Moore and Michael Zavet to speak on Thursday, January 27 at 4:25pm ESTVancouver, British Columbia--(Newsfile Corp. - January 27, 2022) - HAVN Life Sciences Inc. (CSE: HAVN) (OTC Pink: HAVLF) (FSE:...
HAVN Life Announces Supply and Distribution MOU with Mycrodose Therapeutics
The partnership is a integral step in the The Company's path to market in the U.S., achieving one of its most important milestones to-date VANCOUVER, BC / ACCESSWIRE / September 23, 2021 / Havn Life S...
HAVN Life Announces Distribution Deal with Horizon Grocery + Wellness
VANCOUVER, BC / ACCESSWIRE / September 21, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction o...
HAVN Life Signs Agreement to Supply Psilocybin for Mycotopia Therapies
The partnership will further industry growth for naturally derived psilocybin VANCOUVER, BC / ACCESSWIRE / August 25, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" ...
HAVN Life Harvests First Crop of Psilocybin Mushrooms at its Jamaica Facility
HAVN Life will export to Delic Labs in Canada for quality control and testing. This makes HAVN Life the first in the Caribbean Community and Common Market to export psilocybin.
HAVN Life Signs Agreement to Enable Export of Psilocybin into Canada, the US and Europe
The Agreement with P.A. Benjamin Manufacturing Company whom operates a GMP compliant facility in Jamaica VANCOUVER, BC / ACCESSWIRE / July 27, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)...
HAVN Life Signs Exclusive Supply Agreement With Cube Psytech
The Company will supply naturally-derived psilocybin for the development of psilocybin microdosing health products VANCOUVER, BC / ACCESSWIRE / July 8, 2021 / Havn Life Sciences Inc. (CSE:HAVN) (OTC P...
HAVN Life Sciences Signs Finished Goods Supply Agreement with Allied Health
The Agreement will utilize HAVN Life's fully integrated supply chain model, from the growing of psilocybin through to extraction, compounding, and encapsulation VANCOUVER, BC / ACCESSWIRE / June 29, 2...
HAVN Life Announces Retail Partnership with Grocer, Choices Markets
Newly-launched line of natural health products to be available at all locations later this month VANCOUVER, BC / ACCESSWIRE / June 8, 2021 / HAVN Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5N...
HAVN Life Launches New Line of Natural Health Products
Seven New Formulations That Support Brain Health and Immune Function Will Be Available Online and at Select Retail Locations Starting June 3 VANCOUVER, BC / ACCESSWIRE / June 3, 2021 / HAVN Life Scien...
HAVN Life Completes Acquisition of Clinical Stage IP for Development of Cluster Headache Drug
The Company will seek Orphan Drug Designation to significantly reduce time to market VANCOUVER, BC / ACCESSWIRE / June 2, 2021 / HAVN Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Com...
HAVN Life Secures Production & Supply Agreement to Expand Retail Product Offerings
Natural Health Products Will Be Manufactured and Packaged at the Company's New Facility VANCOUVER, BC / ACCESSWIRE / May 19, 2021 / HAVN Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the ...
HAVN Life Enters into Agreement to Acquire Clinical Stage IP for Development of LSD-Derived API for Cluster Headaches
HAVN Life works towards substantiating a patent application and preclinical work VANCOUVER, BC / ACCESSWIRE / May 17, 2021 / HAVN Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company...
Havn Life CEO Tim Moore to Appear at Upcoming Q2 Investor SummitHavn Life CEO Tim Moore to Appear at Upcoming Q2 Investor Summit
Havn Life will join 80+ other small cap and micro-cap companies at leading event for investors VANCOUVER, BC / ACCESSWIRE / May 14, 2021 / Havn Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP)...
Havn Life Signs Exclusive Supply Agreement with ATMA Journey Centers
Havn Life to supply naturally-derived psilocybin to ATMA Journey Centers in Alberta and Nicoya Peninsula, Costa Rica VANCOUVER, BC / ACCESSWIRE / May 13, 2021 / Havn Life Sciences Inc. (CSE:HAVN) (OTC...
Havn Life Develops New Method for Rapid Psilocybin Testing
Havn Life has completed its analytical work under its Health Canada Section 56 exemption VANCOUVER, BC / ACCESSWIRE / May 11, 2021 / Havn Life Sciences Inc. (CSE: HAVN) (OTC PINK: HAVLF) (FSE: 5NP)...
Havn Labs Jamaica Facility Now Fully Operational
The Company has started production of its first grow with local partner Hypha Wellness VANCOUVER, BC / ACCESSWIRE / May 4, 2021 / Havn Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Co...
Havn Life Completes Acquisition of Strategic Manufacturing & Packaging Facility for its Retail Division
The Facility acquisition positions Havn Life to quickly expand its product portfolio and reach additional NHP categories. VANCOUVER, BC / ACCESSWIRE / April 8, 2021 / Havn Life Sciences Inc. (CSE:HAVN...
Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin with Jamaican Company Hypha Wellness
Havn Life believes operations can advance its business plan and potentially accelerate production of naturally-derived psilocybin for global medical research. VANCOUVER, BC / ACCESSWIRE / March 25, 20...
Havn Life CEO to Present at Zooming with LD, a Leading Platform for Microcap Companies
CEO Tim Moore will appear on Tuesday, March 24th at 8:00 AM PT/ 11:00 AM ET VANCOUVER, BC / ACCESSWIRE / March 19, 2021 / Havn Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company" o...
Havn Life Introduces Industry Leader Jenna Pozar as Chief Operating Officer
Pozar will lead sales, marketing, e-commerce and logistics for Havn Retail VANCOUVER, BC / ACCESSWIRE / March 16, 2021 / Havn Life Sciences Inc. (CSE:HAVN) (OTC PINK:HAVLF) (FSE:5NP) (the "Company" or...